- Report
- January 2026
- 185 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 192 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 199 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 199 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 193 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 196 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 181 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 193 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- January 2026
- 197 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 185 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- November 2026
- 377 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 383 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 172 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 194 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 470 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 468 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 467 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 285 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 481 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- November 2026
- 282 Pages
Global
From €5424EUR$5,850USD£4,537GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more